Clinical trial

Beneficial Effects of Quercetin in Chronic Obstructive Pulmonary Disease (COPD)

NCT01708278

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-02-01

PhasePHASE1

Study timeline

Study start (unknown)2014-02-01Date precision: month

Registry last updated2016-12-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Chronic Obstructive Pulmonary Diseaseunresolved

Interventions

QuercetinDRUG · verified · RxNorm: quercetin

Placebo - sugar chewOTHER

Sponsors & collaborators

University of Michiganlead sponsor

National Institutes of Health (NIH)collaborator

Quercegen Pharmaceuticalscollaborator

National Center for Complementary and Integrative Health (NCCIH)collaborator

Mapped research locations

Ann ArborMichigan, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01708278 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.